Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.8 USD | -1.84% | -7.25% | -26.72% |
05-13 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
05-08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.72% | 201M | |
+9.85% | 74.45B | |
+11.35% | 9.18B | |
-12.85% | 5.02B | |
+60.16% | 5.03B | |
+1.60% | 3.82B | |
-19.20% | 2.41B | |
+18.65% | 2.39B | |
+24.62% | 2.26B | |
-27.46% | 2.27B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- HC Wainwright Cuts KemPharm's Price Target to $10 From $11, Reiterates Buy Rating